201 related articles for article (PubMed ID: 33552061)
1. Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia.
Du SH; Xiang YJ; Liu L; Nie M; Hou Y; Wang L; Li BB; Xu M; Teng QL; Peng J; Hou M; Shi Y
Front Immunol; 2020; 11():603278. PubMed ID: 33552061
[TBL] [Abstract][Full Text] [Related]
2. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity.
Basler M; Lindstrom MM; LaStant JJ; Bradshaw JM; Owens TD; Schmidt C; Maurits E; Tsu C; Overkleeft HS; Kirk CJ; Langrish CL; Groettrup M
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30279279
[TBL] [Abstract][Full Text] [Related]
3. Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages.
Chen S; Kammerl IE; Vosyka O; Baumann T; Yu Y; Wu Y; Irmler M; Overkleeft HS; Beckers J; Eickelberg O; Meiners S; Stoeger T
Cell Death Differ; 2016 Jun; 23(6):1026-37. PubMed ID: 26990663
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor-α Blockade Corrects Monocyte/Macrophage Imbalance in Primary Immune Thrombocytopenia.
Zhao Y; Xu P; Guo L; Wang H; Min Y; Feng Q; Hou Y; Sun T; Li G; Ji X; Qiu J; Peng J; Liu X; Hou M
Thromb Haemost; 2021 Jun; 121(6):767-781. PubMed ID: 33469903
[TBL] [Abstract][Full Text] [Related]
5. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
[TBL] [Abstract][Full Text] [Related]
6. Immunoproteasomal Inhibition With ONX-0914 Attenuates Atherosclerosis and Reduces White Adipose Tissue Mass and Metabolic Syndrome in Mice.
Schaftenaar FH; van Dam AD; de Bruin G; Depuydt MAC; de Mol J; Amersfoort J; Douna H; Meijer M; Kröner MJ; van Santbrink PJ; Bernabé Kleijn MNA; van Puijvelde GHM; Florea BI; Slütter B; Foks AC; Bot I; Rensen PCN; Kuiper J
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1346-1364. PubMed ID: 38660806
[TBL] [Abstract][Full Text] [Related]
7. Ablation and Inhibition of the Immunoproteasome Catalytic Subunit LMP7 Attenuate Experimental Abdominal Aortic Aneurysm Formation in Mice.
Li FD; Nie H; Tian C; Wang HX; Sun BH; Ren HL; Zhang X; Liao PZ; Liu D; Li HH; Zheng YH
J Immunol; 2019 Feb; 202(4):1176-1185. PubMed ID: 30642978
[TBL] [Abstract][Full Text] [Related]
8. No prolongation of skin allograft survival by immunoproteasome inhibition in mice.
Mundt S; Basler M; Sawitzki B; Groettrup M
Mol Immunol; 2017 Aug; 88():32-37. PubMed ID: 28582644
[TBL] [Abstract][Full Text] [Related]
9. The antiviral immune response in mice devoid of immunoproteasome activity.
Basler M; Beck U; Kirk CJ; Groettrup M
J Immunol; 2011 Dec; 187(11):5548-57. PubMed ID: 22013127
[TBL] [Abstract][Full Text] [Related]
10. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis.
Li J; Hu S; Johnson HWB; Kirk CJ; Xian P; Song Y; Li Y; Liu N; Groettrup M; Basler M
Cardiovasc Res; 2023 May; 119(4):1030-1045. PubMed ID: 36464772
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke.
Chen X; Zhang X; Wang Y; Lei H; Su H; Zeng J; Pei Z; Huang R
Cell Death Dis; 2015 Jan; 6(1):e1626. PubMed ID: 25633295
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
Basler M; Mundt S; Muchamuel T; Moll C; Jiang J; Groettrup M; Kirk CJ
EMBO Mol Med; 2014 Feb; 6(2):226-38. PubMed ID: 24399752
[TBL] [Abstract][Full Text] [Related]
13. Immunoproteasomal Processing of IsoLG-Adducted Proteins Is Essential for Hypertension.
de la Visitación N; Chen W; Krishnan J; Van Beusecum JP; Amarnath V; Hennen EM; Zhao S; Saleem M; Ao M; Dikalov SI; Dikalova AE; Harrison DG; Patrick DM
Circ Res; 2024 May; 134(10):1276-1291. PubMed ID: 38623763
[TBL] [Abstract][Full Text] [Related]
14. Immunoproteasome-specific inhibitors and their application.
Basler M; Groettrup M
Methods Mol Biol; 2012; 832():391-401. PubMed ID: 22350900
[TBL] [Abstract][Full Text] [Related]
15. High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.
Feng Q; Xu M; Yu YY; Hou Y; Mi X; Sun YX; Ma S; Zuo XY; Shao LL; Hou M; Zhang XH; Peng J
J Thromb Haemost; 2017 Sep; 15(9):1845-1858. PubMed ID: 28682499
[TBL] [Abstract][Full Text] [Related]
16. ONX 0914 Lacks Selectivity for the Cardiac Immunoproteasome in CoxsackievirusB3 Myocarditis of NMRI Mice and Promotes Virus-Mediated Tissue Damage.
Neumaier HL; Harel S; Klingel K; Kaya Z; Heuser A; Kespohl M; Beling A
Cells; 2020 Apr; 9(5):. PubMed ID: 32354159
[No Abstract] [Full Text] [Related]
17. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
Li J; Basler M; Alvarez G; Brunner T; Kirk CJ; Groettrup M
Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189
[TBL] [Abstract][Full Text] [Related]
18. The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis.
French T; Israel N; Düsedau HP; Tersteegen A; Steffen J; Cammann C; Topfstedt E; Dieterich D; Schüler T; Seifert U; Dunay IR
Front Immunol; 2021; 12():619465. PubMed ID: 33968021
[TBL] [Abstract][Full Text] [Related]
19. Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide).
Johnson HWB; Lowe E; Anderl JL; Fan A; Muchamuel T; Bowers S; Moebius DC; Kirk C; McMinn DL
J Med Chem; 2018 Dec; 61(24):11127-11143. PubMed ID: 30380863
[TBL] [Abstract][Full Text] [Related]
20. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation.
Kalim KW; Basler M; Kirk CJ; Groettrup M
J Immunol; 2012 Oct; 189(8):4182-93. PubMed ID: 22984077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
